DocWire News Mar 06, 2023
The use of renin-angiotensin system RAS inhibitors including angiotensin-converting-enzyme ACE inhibitors and angiotensin-receptor blockers ARBs Results of a multicenter randomized open-label STOP-ACEi trial of patients with advanced and progressive CKD.